Impact of International Nosocomial Infection Control Consortium's multidimensional approach on central line-associated bloodstream infection rates in Bahrain

J Vasc Access. 2020 Jul;21(4):481-489. doi: 10.1177/1129729819888426. Epub 2019 Dec 10.

Abstract

Background: Central line-associated bloodstream infections are serious life-threatening infections in the intensive care unit setting.

Methods: To analyze the impact of the International Nosocomial Infection Control Consortium (INICC) Multidimensional Approach (IMA) and INICC Surveillance Online System (ISOS) on central line-associated bloodstream infection rates in Bahrain from January 2013 to December 2016, we conducted a prospective, before-after surveillance, cohort, observational study in one intensive care unit in Bahrain. During baseline, we performed outcome and process surveillance of central line-associated bloodstream infection on 2320 intensive care unit patients, applying Centers for Disease Control and Prevention's National Healthcare Safety Network definitions. During intervention, we implemented IMA through ISOS, including (1) a bundle of infection prevention interventions, (2) education, (3) outcome surveillance, (4) process surveillance, (5) feedback on central line-associated bloodstream infection rates and consequences, and (6) performance feedback of process surveillance. Bivariate and multivariate regression analyses were performed using a logistic regression model to estimate the effect of the intervention on the central line-associated bloodstream infection rate.

Results: During baseline, 672 central line days and 7 central line-associated bloodstream infections were recorded, accounting for 10.4 central line-associated bloodstream infections per 1000 central line days. During intervention, 13,020 central line days and 48 central line-associated bloodstream infections were recorded. After the second year, there was a sustained 89% cumulative central line-associated bloodstream infection rate reduction to 1.2 central line-associated bloodstream infections per 1000 central line days (incidence density rate, 0.11; 95% confidence interval 0.1-0.3; p, 0.001). The average extra length of stay of patients with central line-associated bloodstream infection was 23.3 days, and due to the reduction of central line-associated bloodstream infections, 367 days of hospitalization were saved, amounting to a reduction in hospitalization costs of US$1,100,553.

Conclusion: Implementing IMA was associated with a significant reduction in the central line-associated bloodstream infection rate in Bahrain.

Keywords: Hospital infection; blood stream infection; bundle; central line–associated bloodstream infection; critical care; device-associated infection; healthcare-acquired infection; incidence density; intensive care; surveillance; techniques and procedure.

Publication types

  • Observational Study

MeSH terms

  • Adult
  • Bahrain
  • Catheter-Related Infections / diagnosis
  • Catheter-Related Infections / microbiology
  • Catheter-Related Infections / prevention & control*
  • Catheterization, Central Venous / adverse effects*
  • Catheterization, Central Venous / instrumentation*
  • Catheters, Indwelling*
  • Central Venous Catheters*
  • Cross Infection / diagnosis
  • Cross Infection / microbiology
  • Cross Infection / prevention & control*
  • Female
  • Humans
  • Infection Control / standards*
  • Intensive Care Units
  • Male
  • Middle Aged
  • Outcome and Process Assessment, Health Care / standards*
  • Prospective Studies
  • Risk Assessment
  • Risk Factors
  • Time Factors
  • Treatment Outcome